ArticleOral oncology2019

Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass.

Anne M van Harten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.